US Bancorp’s GenMark Diagnostics, Inc GNMK Stock Holding History

US Bancorp’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-185	Closed	-$4K	–	4147
2021 Q1	$4K	Sell	185 -500	-73%	-$9.29K	﹤0.01%	3584
2020 Q4	$10K	Buy	685 +66	+11%	+$875	﹤0.01%	3197
2020 Q3	$9K	Buy	619 +200	+48%	+$3.06K	﹤0.01%	3137
2020 Q2	$6K	Buy	419 +218	+108%	+$2.21K	﹤0.01%	3289
2020 Q1	$1K	Buy	+201	New	+$942	﹤0.01%	3646

US Bancorp's GNMK Position: Q2 2021 in Review

US Bancorp sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 185 shares — an estimated $4K sold.

US Bancorp first reported a position in GNMK in Q1 2020 and held it in 5 quarters. The position peaked at $10K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

US Bancorp reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
US Bancorp sold 185 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $4K.
US Bancorp first reported a position in GenMark Diagnostics, Inc in Q1 2020 and held it in 5 quarters.
US Bancorp's GenMark Diagnostics, Inc position peaked at $10K in Q4 2020.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on US Bancorp's 13F filing for Q2 2021, filed 5 Aug 2021.